Counselors in Ridge, NY Accepting Medicare

5 Counselors found. Showing 1 - 5

Ms. Julia Malcolm Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 35 Eason Dr, Ridge, NY 11961 Phone: 631-345-6501

Yvette Eugenia Brown-sutnick, L.M.H.C. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 778 Whiskey Rd, Ridge, NY 11961 Phone: 718-644-3170    Fax: 631-849-1310

Mrs. Christiana Mcpherson, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1008 Village Dr Apt 1008b, Ridge, NY 11961 Phone: 631-902-1677

Michele Willliams, MS Counselor - School Medicare: Not Enrolled in Medicare Practice Location: 93 Glen Dr, Ridge, NY 11961 Phone: 631-228-4574

Arlette Anneris Dominguez Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 92 Raynor Rd, Ridge, NY 11961 Phone: 347-431-6666

News Archive

Medex signs binding letter of intent to acquire BEE Mobile

Medex, Inc., today announced the signing of a binding letter of intent to acquire privately held BEE Mobile, Inc. Founded in 2008 and headquartered in San Diego, CA, Medicare accredited BEE Mobile services and rents power wheelchairs and scooters as well as high end rehabilitation equipment.

Proteases modulate SARS-CoV-2 spike protein activation and deactivation

A research paper recently uploaded to the preprint server bioRxiv by Platt et al. (17th Feb 2021) aimed to identify these enzymes by computational screening and molecular docking simulations, with cathepsins B, K, L, S, and V being highlighted as probable leads.

Presentation on L-DOS47 drug formulation and development at Pharmaceutical Industry Conference

Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) today announced that a presentation on L-DOS47 formulation and analytical method development will be made at the "Formulation Strategies for Protein Therapeutics" conference to be held on October 13 to 15, 2009, in Raleigh, North Carolina. The conference is sponsored by IBC Life Sciences.

Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Symposium

Enzon Pharmaceuticals, Inc. today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists. These antagonists are based on the locked nucleic acid (LNA) technology platform targets licensed from Santaris Pharma A/S.

Read more Medical News

› Verified 4 days ago